Get the latest Septerna, Inc. (SEPN) stock news and headlines to help you in your trading and investing decisions.

There are hundreds of conditions that have itch as an underlying symptom, according to Brian S. Kim, MD, MTR, the Sol and Clara Kest professor of dermatology and vice chair of research at Icahn School ...

Advancements in itch therapeutics have evolved rapidly, offering patients with various itch-driven diseases multiple options that target the source of their itch. Itch exists on a spectrum, according ...

About Septerna Inc. Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discover ...